Tilray Brands Stock
Tilray Brands, Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- Irwin David Simon
- Employees
- 3,595
- Market cap
- $340 M
- IPO
- 19/07/2018
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America.…
Tilray Brands stock: price history
1D
-5.3%
1W
-14.1%
1M
-22.6%
6M
-55.7%
YTD
-66.3%
1Y
-80.3%
2Y
-80.8%
5Y
-97.0%
10Y
–
Next earnings date
Next earnings date
11/01/2027 (in 86 days)
Volatility around earnings
~5% stronger price swings than usual
Ask the agents about Tilray Brands
Analyst assessment of Tilray Brands
PRICE TARGET LOW
US$10.00
CONSENSUS
US$65.01
MEDIAN
US$41.50
PRICE TARGET HIGH
US$190.00
0
STRONG BUY
4
BUY
14
HOLD
2
SELL
0
STRONG SELL
20
TOTAL · Hold
As of: 09/10/2026
Tilray Brands stock metrics
P/E
-2.17
P/B
0.25
EV/EBITDA
-26.83
RETURN ON EQUITY
-2.7%
NET MARGIN
-16.8%
DEBT/EQUITY
0.23
DIVIDEND YIELD
0.0%
AS OF
31/08/2026
Free float & liquidity
FREE FLOAT
120.1%
FLOAT SHARES
134,292,513
AVG. DAILY VOLUME (30D)
4,090,729
Insider transactions (SEC)
SIMON IRWIN D
SIMON IRWIN D
Merton Carl A
Gendel Mitchell
Merton Carl A
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -5.3%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Tilray Brands stock
What does Tilray Brands do?
Tilray Brands, Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Irwin David Simon, the company employs around 3,595 people.
The IPO was on 19/07/2018; the stock trades on NASDAQ under the ticker TLRY.
What do analysts say about Tilray Brands stock?
20 analysts rate the stock, the consensus is Hold (as of 09/10/2026).
The average price target is US$65.01, ranging from US$10.00 to US$190.00, with a median of US$41.50.
This is an external assessment, not a statement by Market Jury.
When does Tilray Brands report next?
The next earnings date is 11/01/2027.
Around past earnings, price swings were roughly 5% stronger than usual.
Does Tilray Brands pay a dividend?
No, Tilray Brands currently does not pay a dividend.
Which stocks are comparable to Tilray Brands?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Tilray Brands stock analyzed?
Clicking "Analyze stock" lets five strategies assess Tilray Brands against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.